|
|
News Breaks
|
January 5, 2012
|
| 07:28 EDT |  | CORT |
| theflyonthewall.com: | Corcept Therapeutics February 17 PDUFA date previewed at Leerink | | Leerink previewed Corcept's February 17 PDUFA date for Korlyn for Cushing's syndrome, saying the company's indications that no panel will be required, and that no REMS will be required, bode well for approval. Leerink says it’s warming up to Corcept Therapeutics shares, but reiterates a Market Perform rating on the stock. Note BioLogic Equity this morning initiated shares of Corcept Therapeutics with a Sell rating, saying investors should not own name in the PDUFA date. :theflyonthewall.com |
|
|
News For CORT From The Last 14 Days Check below for free stories on CORT the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 24, 2012
|
| 17:22 EDT |  | CORT |
|
|
|
|
|
Subscribe for More Information